Grade 4 IDH-mutant astrocytomas are defined by the presence of microvascular proliferation, necrosis, and/or homozygous deletion of cyclin-dependent kinase inhibitor 2A/B (CDKN2A/B) in IDH-mutant astrocytoma. The gene discussed is CDKN2A; the disease is astrocytoma (excluding glioblastoma).